SMA (Spinal Muscular Atrophy) is a genetic and progressive muscle disease that leads to the loss of motor nerve cells that control muscles. The disease affects vital muscle functions such as movement, swallowing and breathing.
What is Diagnosis?
SMA is diagnosed with genetic tests. Today, thanks to neonatal screening tests, the disease can be detected without symptoms.
The Importance of Early Diagnosis:
Early diagnosis is vital in SMA. The earlier the treatment is started:
Muscle loss can be greatly avoided
The progression of the disease can be slowed
The quality and duration of the child's life increases significantly
Frequency of Seeing in the World and in Turkey:
1 case of SMA is seen in approximately every 6,000–10,000 births worldwide.
Approximately one out of every 40–60 people in the community is an SMA carrier.
What is the Risk If No Measures Are Taken?
If the mother and father are SMA carriers:
25% chance of sick child
50% likely carrier child
There is a 25% chance of being born a healthy child
For this reason, premarital and pre-pregnancy screening tests are of great importance.
Treatment and Drug Cost:
Drugs developed for SMA do not completely eliminate the disease but can stop or slow its progression.
The cost of single-dose gene therapy and other drugs can reach millions of dollars. This makes early diagnosis and preventive health policies even more critical.
SMA'sız Yarınlar Social Responsibility Project - Letterhead and Newspaper Page Design
SMA'sız Yarınlar Social Responsibility Project - Brochure Designs
SMA'sız Yarınlar Social Responsibility Project - Mobile and Web Site Designs
